PYRROLOPYRIMINDINE CDK9 KINASE INHIBITORS
Disclosed are compound of Formula (Ia), wherein R1, R2, and R3 are as defined in the specification, and pharmaceutically acceptable salts thereof. The compounds may be used as agents in the treatment of diseases, including cancer. Also provided are pharmaceutical compositions, comprising one or more...
Saved in:
Main Authors | , , , , |
---|---|
Format | Patent |
Language | English French |
Published |
02.10.2014
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Disclosed are compound of Formula (Ia), wherein R1, R2, and R3 are as defined in the specification, and pharmaceutically acceptable salts thereof. The compounds may be used as agents in the treatment of diseases, including cancer. Also provided are pharmaceutical compositions, comprising one or more compounds of Formula (Ia).
L'invention concerne un composé de Formule (Ia), où R1, R2 et R3 sont tels que définis dans la description, et des sels pharmaceutiquement acceptables de celui-ci. Les composés peuvent être utilisés en tant qu'agents dans le traitement de maladies, comprenant le cancer. L'invention concerne également des compositions pharmaceutiques comprenant un ou plusieurs composés de Formule (Ia). |
---|---|
AbstractList | Disclosed are compound of Formula (Ia), wherein R1, R2, and R3 are as defined in the specification, and pharmaceutically acceptable salts thereof. The compounds may be used as agents in the treatment of diseases, including cancer. Also provided are pharmaceutical compositions, comprising one or more compounds of Formula (Ia).
L'invention concerne un composé de Formule (Ia), où R1, R2 et R3 sont tels que définis dans la description, et des sels pharmaceutiquement acceptables de celui-ci. Les composés peuvent être utilisés en tant qu'agents dans le traitement de maladies, comprenant le cancer. L'invention concerne également des compositions pharmaceutiques comprenant un ou plusieurs composés de Formule (Ia). |
Author | PENNING, THOMAS TONG, YUNSONG GOSWAMI, RAJEEV SOUERS, ANDREW J FLORJANCIC, ALAN S |
Author_xml | – fullname: FLORJANCIC, ALAN S – fullname: GOSWAMI, RAJEEV – fullname: TONG, YUNSONG – fullname: SOUERS, ANDREW J – fullname: PENNING, THOMAS |
BookMark | eNrjYmDJy89L5WTQDIgMCvL38QdSnr6efi6efq4Kzi7elgrenn6Owa4Knn4enk6eIf5BwTwMrGmJOcWpvFCam0HZzTXE2UM3tSA_PrW4IDE5NS-1JD7c38jA0MTQzMDAyMLR0Jg4VQDY-ydO |
ContentType | Patent |
DBID | EVB |
DatabaseName | esp@cenet |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Sciences |
DocumentTitleAlternate | INHIBITEURS DE PYRROLOPYRIMIDINE CDK9 KINASE |
ExternalDocumentID | WO2014160028A1 |
GroupedDBID | EVB |
ID | FETCH-epo_espacenet_WO2014160028A13 |
IEDL.DBID | EVB |
IngestDate | Fri Jul 19 15:30:43 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | English French |
LinkModel | DirectLink |
MergedId | FETCHMERGED-epo_espacenet_WO2014160028A13 |
Notes | Application Number: WO2014US25670 |
OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20141002&DB=EPODOC&CC=WO&NR=2014160028A1 |
ParticipantIDs | epo_espacenet_WO2014160028A1 |
PublicationCentury | 2000 |
PublicationDate | 20141002 |
PublicationDateYYYYMMDD | 2014-10-02 |
PublicationDate_xml | – month: 10 year: 2014 text: 20141002 day: 02 |
PublicationDecade | 2010 |
PublicationYear | 2014 |
RelatedCompanies | ABBVIE INC |
RelatedCompanies_xml | – name: ABBVIE INC |
Score | 2.952404 |
Snippet | Disclosed are compound of Formula (Ia), wherein R1, R2, and R3 are as defined in the specification, and pharmaceutically acceptable salts thereof. The... |
SourceID | epo |
SourceType | Open Access Repository |
SubjectTerms | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES |
Title | PYRROLOPYRIMINDINE CDK9 KINASE INHIBITORS |
URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20141002&DB=EPODOC&locale=&CC=WO&NR=2014160028A1 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1bS8MwFD6MKeqbTsXplIJS8KFYu7ZpH4asN1p1TemqzqfRrgkIMoer-Pc9jZ3uaU-5QW7w5eTLuQTgiui5wTi7VUpiqYrOVa4Utl0qGiFWaeeYF4HnR7EZPun3E2PSgveVL4yIE_otgiMiomaI90qc14v_RyxP2FYub4o3rPq4C7KBJzfsuDZaVDXZcwZ-Qj3qyq6LvE2O09-2WgdlDZErbeFFmtR48J-d2i9lsS5Ugn3YTrC_eXUALTbvwK67-nutAzujRuWN2QZ9y0O4Tl7TlD5STPDIib0o9iXXe7AlpODDsS9FcRg5UUbT8RFcBn7mhgqOOf1b4vSFrk-wfwxtJP_sBKQSZaxBOC-IruqEsdxSTV7YfZPxGe5u3oXepp5ONzefwV5dFMZpWg_a1ecXO0chWxUXYm9-AIR4e3I |
link.rule.ids | 230,309,783,888,25576,76876 |
linkProvider | European Patent Office |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_GFOebTsWPqQWl4EOxdm3TPgxZv2jd-kFXdXsa7ZqAIHO4iv--17jpnvaUkINLcnB3-eUuF4BbouYaZfRBKokhSyqTmVSYZikphBilmWOfF54PI91_Vp_G2rgB7-u3MLxO6DcvjogaNUN9r7i9XvxfYjk8t3J5X7zh0Mejl_UccYWO66RFWREdq-cmsRPbom0jbhOj9JdWx6CMPmKlHTxkk1of3Berfpey2HQq3gHsJshvXh1Cg87b0LLXf6-1YS9chbyxu9K-5RHcJZM0jYcxNmhyIieIXMF2BqaAELw_coUg8gMryOJ0dAw3npvZvoRzTv-2OH2NNxfYPYEmgn96CkKJPlYjjBVElVVCaW7IOivMrk7ZDKWbn0FnG6fz7eRraPlZOJwOg2hwAfs1iSeqKR1oVp9f9BIdblVccTn9AHn8fmU |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=PYRROLOPYRIMINDINE+CDK9+KINASE+INHIBITORS&rft.inventor=FLORJANCIC%2C+ALAN+S&rft.inventor=GOSWAMI%2C+RAJEEV&rft.inventor=TONG%2C+YUNSONG&rft.inventor=SOUERS%2C+ANDREW+J&rft.inventor=PENNING%2C+THOMAS&rft.date=2014-10-02&rft.externalDBID=A1&rft.externalDocID=WO2014160028A1 |